PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 162 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $1,243,000 | +2.4% | 147,303 | +6.2% | 0.52% | +22.2% |
Q4 2019 | $1,214,000 | -37.7% | 138,729 | -20.6% | 0.43% | -42.5% |
Q3 2019 | $1,949,000 | +20.7% | 174,641 | +37.5% | 0.74% | +25.5% |
Q2 2019 | $1,615,000 | +3.7% | 127,029 | +71.9% | 0.59% | -14.2% |
Q1 2019 | $1,558,000 | 0.0% | 73,876 | 0.0% | 0.69% | +3.6% |
Q4 2018 | $1,558,000 | -13.3% | 73,876 | +88.4% | 0.67% | +8.1% |
Q3 2018 | $1,796,000 | -12.2% | 39,209 | +8.0% | 0.62% | -18.5% |
Q2 2018 | $2,045,000 | +14.6% | 36,297 | +38.4% | 0.76% | +3.0% |
Q1 2018 | $1,785,000 | +21.1% | 26,229 | +75.9% | 0.73% | +15.2% |
Q4 2017 | $1,474,000 | -17.4% | 14,909 | 0.0% | 0.64% | -20.1% |
Q3 2017 | $1,785,000 | +8.2% | 14,909 | -21.0% | 0.80% | +6.1% |
Q2 2017 | $1,650,000 | +69.9% | 18,874 | -27.7% | 0.75% | +94.1% |
Q1 2017 | $971,000 | +767.0% | 26,105 | +1649.7% | 0.39% | +578.9% |
Q3 2015 | $112,000 | -35.6% | 1,492 | 0.0% | 0.06% | -27.8% |
Q2 2015 | $174,000 | -50.6% | 1,492 | 0.0% | 0.08% | -50.9% |
Q1 2015 | $352,000 | – | 1,492 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |